🇺🇸 abatacept, rituximab or tocilizumab in United States

abatacept, rituximab or tocilizumab (abatacept, rituximab or tocilizumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

abatacept, rituximab or tocilizumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is abatacept, rituximab or tocilizumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for abatacept, rituximab or tocilizumab in United States?

University Hospital, Strasbourg, France is the originator. The local marketing authorisation holder may differ — check the official source linked above.